CURRICULUM VITAE
Shikha Singla MD
Shikha Singla MD
Associate Professor
Department of Medicine
Division of Rheumatology
Department of Medicine
Division of Rheumatology
OFFICE ADDRESS: |
Hub for Collaborative Medicine |
8701 Watertown Plank Road |
Milwaukee, WI 53226 |
EDUCATION: |
01/2000 - 09/2005 MD, Manipal College of Medical Sciences (MCOMS), Nepal |
09/2004 - 10/2004 Internship, Dr. Ram Manohar Lohia Hospital, India |
10/2004 - 09/2005 Internship, Kasturba Medical College, India |
07/2008 - 06/2011 Resident, Internal Medicine, Mercer University School of Medicine, Macon, GA |
07/2013 - 06/2015 Fellowship - Rheumatology, Ochsner Medical Center, New Orleans, LA |
FACULTY APPOINTMENTS: |
09/2015 - 05/2019 Attending Rheumatologist, Rheumatology, Ochsner Healthcare Network, New Orleans, LA |
07/01/2019 - Present Assistant Professor, Medicine, Rheumatology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53151 |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
07/2022 - Present Medical Director, Psoriatic Arthritis Program, Medicine, Rheumatology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226 |
RESEARCH ADMINISTRATIVE APPOINTMENTS: |
07/2007 - 06/2008 Primary Research Coordinator, Advocate Lutheran General Hospital, IL |
HOSPITAL STAFF PRIVILEGES: |
01/2007 - 03/2007 Medical Assistant, Condell Medical Center, IL |
08/2011 - 06/2013 Hospitalist, Taylor Hospital, PA |
08/2015 - 06/2019 Rheumatologist, Oschner Medical Center, Slindell, LA |
07/01/2019 - Present Rheumatologist, Froedtert Hospital, 9200 W. Wisconsin Avenue, Milwaukee, WI 53226 |
07/01/2019 - Present Rheumatologist, Froedtert Dermatology Clinic, 601 N. 99th Street, Milwaukee, WI 53225 |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Internal Medicine | 2011 | 12/31/2021 |
ABIM - Rheumatology | 2015 | 12/31/2025 |
AWARDS AND HONORS: |
06/1999 National prize for getting 100% on board exam, India |
05/2008 First place poster presentation, Northwestern Clinical Research Conference - Chicago IL |
09/2022 Featured in Women in Medicine Campaign , Medical College of Wisconsin |
12/2023 Article featured as the “Best of 2023" on the forum, RheumNow |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2014 - Present Association of Women in Rheumatology (AWIR) - (Member) (Member) |
2021 - Present National Psoriasis Foundation (Member) |
2021 - Present Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) (Member) |
2024 - Present Arthritis Foundation, WI (Medical Chair) |
2024 - Present Spondyloarthritis Research and Treatment Network (SPARTAN) (Member) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorship |
03/2025 - Present Associate Editor, Rheumatology Advances and Practice |
Editorial Board |
10/2023 - 03/2025 Rheumatology Advances in Practice |
Journal Review |
07/2023 The Lancet, Rheumatology |
2023 - Present Rheumatology Advances in Practice |
03/2024 Exploration of Musculoskeletal Diseases |
04/2024 Therapeutic Advances in Musculoskeletal Disease |
07/2024 Rheumatic and Musculoskeletal Diseases Open |
09/2024 British Journal of Dermatology |
03/2025 Rheumatology |
04/2025 Rheumatology |
05/2025 Archives of Dermatological Research |
Ad-Hoc Reviewer |
12/2024 Global Health, Department of Medicine Annual Research Meeting, MCW |
01/2025 - 02/2025 EULAR 2025 Congress |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2023 - 2024 Member, Search Committee/Dermatology Chair, Medical College of Wisconsin |
09/2024 - 10/2024 Member, Fellowship Selection Committee, Medical College of Wisconsin |
2024 - Present Research Pillar Lead, Global Health Steering Committee, Medical College of Wisconsin |
2025 - Present Member, Clinical Research Subcommittee, Medical College of Wisconsin |
INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2023 - Present Member - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) engagement committee |
2024 - Present Member - Spondyloarthritis Research and Treatment Network (SPARTAN) |
2025 - Present Young Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) research subcomittee |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Association between biologic immunotherapy for psoriasis and time to incident inflammatory arthritis, IMMUNEFORUM, Virtual, 08/2023 |
Health Care Provider Survey for Difficult to Treat Psoriatic arthritis, Group for Research and Assessment of Psoriasis and Psoriasis Arthritis Adjacent to American College of Rheumatology, San Diego, CA, 11/2023 |
Psoriatic Arthritis - Year in Review, Axial Spondylarthritis/Psoriatic Arthritis Symposium, American College of Rheumatology, Washington, DC, 11/2024 |
Debate: Can Psoriatic be Prevented in Patients with Psoriasis?, American Academy of Dermatology 2025, Orlando, FL, 03/2025 |
Difficult to treat Psoriatic Arthritis, Invited lecture, Lucknow, UP, India, 03/2025 |
Regional |
Difficult to Treat Psoriatic Arthritis, Michigan Rheumatism Society, Mackinac Island, MI, 06/2024 |
Local |
Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study, MCW Dermatology Journal Club, Milwaukee, WI, 07/2023 |
Spondyloarthritis: A Review, MCW Department of Medicine Grand Rounds, Virtual, 12/2023 |
Rheumatologic Manifestations of IBD, MCW Inflammatory Bowel Disease Update, Wauwatosa, WI, 04/2024 |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
International |
Singla S, Chen M, Pounds J, Khan O, Zakem J, Collins K, Webb-Detiege T, Davis W, Quinet R, Zhang X., Follicular Helper T Cells Control Autoimmunity through IL-21/IL-21 Receptor Interaction in RA Patients. Poster presentation, ACR Annual Meeting, Boston, MA, 11/2014 |
Budziakowska M, Shahzad A, Pounds J, Sigla S, Zakem JJ, Collins K, Webb-Detiegel T, Davis W, Yu Z, Quinet R, Zhang X, A Novel Paradigm in the Clinical Context of Rheumatoid Arthritis Role of Tfh and Th17 Cells in Autoimmunity - Poster, American College of Rheumatology Annual Meeting, San Francisco, CA, 11/2015 |
Stefl A, Singla S, Michaud J, Thomas K, Rein L, Csuka, ME, Assessment and Treatment of Glucocorticoid-Induced Osteoporosis in a Rheumatology Clinic - Poster, American College of Rheumatology Annual Meeting, Virtual, 11/2020 |
Roy D, Andreoli L, Ovseiko PV, Dzifa D, Ravindran Y, Arredondo-González AM, Singla S, Toro-Gutierrez CE,Gupta L., Eminence Awards In Rheumatology: A Gender Equity Analysis Across International Society Data, European Alliance of Associations for Rheumatology, 2024, Vienna, Austria, 06/2024 |
Ribeiro A, Singla S, Chandran V, Chronis N, Liao W, Lindsay C, Soriano ER, Mease PJ, Proft F., Decoding The Complexity Of Refractory Psoriatic Arthritis: Results From A Global Healthcare Survey Informed By Grappa Specialists’ Expertise, European Alliance of Associations for Rheumatology, 2024, Vienna, Austria, 06/2024 |
Gill B, Geiger J, Liew J, Putman M, Singla S, Choice of biologic immunotherapy for psoriasis or psoriatic arthritis not associated with risk of major adverse cardiac events, GRAPPA 2024 Annual Meeting and Trainee Symposium, Seattle, WA, 07/2024 |
Anumolu N, Rosenthal A, Sherman K, Singla S, Higher Rates of Psoriatic Arthritis in Patients with Calcium Pyrophosphate Deposition Disease Than Controls: A Retrospective Cohort Study in US Veterans, ACR Annual Meeting, Washington, D.C., 11/2024 |
Mirza M, Liew J, Putman M, Singla S, Secular Trends in Biologic Prescribing for Psoriasis and Psoriatic Arthritis, 2014-2024, ACR Annual Meeting, Washington, D.C., 11/2024 |
Oelke K, Edson-Heredia E, Ross S, Lisse J, Pustizzi J, Sheikhi Mehrabadi A, Bello Vega N, Murphy F, Singla S, Raychaudhuri SP, Baseline Characteristics of Patients with Psoriatic Arthritis Treated with Ixekizumab or Interleukin-23 Inhibitors and Interim Effectiveness Results from an Observational Study in the US, ACR Annual Meeting, Washington, D.C., 11/2024 |
Gill B, Geiger J, Liew J, Putman M, Singla S, Choice of Biologic Immunotherapy for Psoriasis or Psoriatic Arthritis Not Associated with Risk of Major Adverse Cardiac Events, ACR Annual Meeting, Washington, D.C., 11/2024 |
Geiger J, Gill B, Liew J, Putman M, Singla S, Choice of biologic immunotherapy for psoriasis or psoriatic arthritis
not associated with risk of major adverse cardiac events, American College of Cardiology 2025, Chicago, IL, 03/2025 |
Panigrahi S, Mahindrakar N, Singla S, Kumar S, Gudu T, Gupta L, Efficacy of Interventions in Randomised Controlled Trials to Alleviate Physician Burnout: A Systematic Review Informing Suggested Interventions for Rheumatologists, European Alliance of Associations for Rheumatology, 2025, Barcelona, Spain, 06/2025 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-Label Persistence Through 24 Months in Patients with Psoriatic Arthritis Using Guselkumab or Subcutaneous Interleukin-17A Inhibitors, European Alliance of Associations for Rheumatology, 2025, Barcelona, Spain, 06/2025 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-Label Persistence Through 24 Months Among Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous TNF Inhibitors, European Alliance of Associations for Rheumatology, 2025, Barcelona, Spain, 06/2025 |
Oelke K, Edson-Heredia E, Ross S, Lisse J, Pustizzi J, Sheikhi Mehrabadi A, Bello Vega N, Murphy F, Singla S, Raychaudhuri SP, Ixekizumab or Interleukin-23 Inhibitors in Patients with Psoriatic Arthritis: Key Real-World Outcomes from the Prospective Observational PARTUS Study in the US, European Alliance of Associations for Rheumatology, 2025, Barcelona, Spain, 06/2025 |
Proft F, Ribeiro AL, Singla S, Chandran V, Liao W, Lindsay C, Soriano ER, Bhutani T, Deodhar A, de Vlam K, Eder L, Kishimoto M, Leung YY, Lubrano E, McGonagle D, Poddubnyy D, Savage L, van den Bosch F, Mease PJ, Establishing Definitions for Difficult-To-Treat Psoriatic Arthritis (D2t-Psa) and Complex-To-Manage Psoriatic Arthritis (C2m-Psa): Insights from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Initiative, European Alliance of Associations for Rheumatology, 2025, Barcelona, Spain, 06/2025 |
National |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-label persistence through 24 months among patients with psoriatic arthritis initiating guselkumab or subcutaneous TNF inhibitors, Congress of Clinical Rheumatology (CCR West 2024), San Diego, CA, 09/2024 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-label persistence through 24 months in patients with psoriatic arthritis using guselkumab or subcutaneous interleukin-17A inhibitors, Congress of Clinical Rheumatology (CCR West 2024), San Diego, CA, 09/2024 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, Comparison of On-Label Treatment Persistence Through 24 Months in Real-World Biologic-Naïve and Biologic-Experienced Patients with Psoriatic Arthritis Treated with Guselkumab versus Subcutaneous IL-17A Inhibitors, Maui Derm 2025, Maui, HI, 01/2025 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, Real-World On-Label Treatment Persistence Through 24 Months in Biologic-Naïve and Biologic-Experienced Patients With Psoriatic Arthritis: Comparison of Guselkumab versus Subcutaneous Tumor Necrosis Factor Inhibitors, Maui Derm 2025, Maui, HI, 01/2025 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-Label Persistence Through 24 Months Among Patients with Psoriatic Arthritis Initiating Guselkumab or Subcutaneous TNF Inhibitors, Rheumatology Winter Clinical Symposium (RWCS 2025), Maui, HI, 02/2025 |
Mease PJ, Walsh JA, Fitzgerald T, Chakravarty SD, Emond B, Rossi C, Schwartzbein S, Yokoji K, Wang Y, Lefebvre P, Pilon D, Hou L, Singla S, Merola JF, On-Label Persistence Through 24 Months in Patients with Psoriatic Arthritis Using Guselkumab or Subcutaneous Interleukin-17A Inhibitors, Rheumatology Winter Clinical Symposium (RWCS 2025), Maui, HI, 02/2025 |
Regional |
Singla S, Gunasekaran TS, Dahlberg M, Is Gastroscope Better Than Colonoscope in Pediatric Colonoscopy? Presentation, Northwestern Clinical Research Conference, Chicago, IL, 05/2008 |
Singla S, Samoson A, Beaulieu E, Grimsley EW, Rare Case Of Isolated Duodenal Variceal Bleeding. Poster presentation, ACP Georgia Chapter, Savannah, GA, 02/2009 |
Reid S, Wigfield S, Mysliwiec T, Perez K, Singla S, Machaud J., Recombinant Zoster Vaccine Immunization Rate in Patients on Janus Kinase Inhibitors for Rheumatologic and Dermatologic Conditions. Poster Presentation, Wisconsin Pharmacy Residency Conference, Madison, WI, 04/2024 |
Local |
Singla S, Beaulieu E., Nephrotic Syndrome Presenting As Myositis. Poster presentation, ACP Georgia Chapter, Atlanta, GA, 04/2010 |
Singla S, Putman M, Liew J, Gordon K, Association between biologic immunotherapy for psoriasis and time to incident inflammatory arthritis. Oral presentation, MCW Department of Medicine Research Retreat, Milwaukee, WI, 03/2023 |
Geiger J, Gill B, Liew B, Putman M, Singla S, Choice of biologic immunotherapy for psoriasis or psoriatic arthritis
not associated with risk of major adverse cardiac events, MCW Department of Medicine Research Retreat, Milwaukee, WI, 03/2025 |
Mirza M, Liew J, Putman M, Singla S, Secular Trends in Biologic Prescribing for Psoriasis and Psoriatic Arthritis, 2014-2024, MCW Department of Medicine Medical Retreat, Milwaukee, WI, 03/2025 |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
07/2019 - Present Teach M4 students on rounds and in Rheumatology clinic and inpatient consult service |
07/2019 - Present M3 Ambulatory Rheumatology Elective. One student per two-week rotation
|
07/2019 - Present M4 Ambulatory Rheumatology Elective. One student per four-week rotation |
07/01/2022 - Present Preceptor - M1 clinical apprenticeship |
12/06/2023 Bedside Teaching mode session for M3 students |
Resident and Fellow Education |
09/2019 - Present Yearly Department of Medicine Academic half-day presentation |
02/2020 Rheumatology Division Journal Club: Targeting ultrasound remission in early rheumatoid arthritis: The results of the TaSER study, a randomized clinical trial |
02/2020 Rheumatology Division Journal Club: Ultrasound in management of rheumatoid arthritis: ARCTIC randomized controlled strategy trial |
12/2020 Rheumatology Division Journal Club: Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results from a Randomized, Controlled Phase III Trial |
12/2020 Rheumatology Division Journal Club: Effect of biologics on radiographic progression of peripheral joints in patients with psoriatic arthritis: meta-analysis |
05/27/2021 - Present Yearly Consultation-Liaison Psychiatry Fellowship Didactics: The Psychiatric Aspects of Rheumatology Disorders, Chronic Fatigue and Fibromyalgia |
05/2022 Rheumatology Division Journal Club: Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years |
05/2022 Rheumatology Division Journal Club: Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologist's Evaluations with Radiologist's findings |
02/2023 Rheumatology Division Journal Club: Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axian spondyloarthritis: A randomized controlled noninferiority trial |
02/2023 Rheumatology Division Journal Club: Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2 year clinical and MRI outcomes and predictors of successful tapering |
12/09/2024 Internal Medicine Resident Global Health Noon Report - Resident Respite room |
05/2025 Journal Club:Sex Differences in the Effectiveness of First-Line
Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis:
Results From the European Spondyloarthritis Research
Collaboration Network |
05/2025 Journal Club:Sex-related differences in patient characteristics, and efficacy
and safety of advanced therapies in randomised clinical trials
in psoriatic arthritis: a systematic literature review and
meta-analysis |
Continuing Medical Education |
12/15/2023 Spondyloarthritis: A Review |
04/2024 Inflammatory Bowel Disease Update |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
High School Students |
08/2024 Alexander Frick, Career advancement, Medical College of Wisconsin, Career placement |
08/2024
Isabela Keller, Career advancement, Medical College of Wisconsin, Career placement |
Medical Students |
07/2023 - 06/2024 Natalie Anumolu, Research Advisor, Medical College of Wisconsin, Submitted abstract for national presentation |
Clinical/Research Fellows |
07/2023 - 06/2024 Bonit Gill, Research Advisor, Medical College of Wisconsin, International poster presentation at GRAPPA |
07/2024 - Present Alexa Reis, Research Advisor, Medical College of Wisconsin |
Pharmacy Students |
07/2023 - 06/2024 Shelby Reid, Research Advisor, Medical College of Wisconsin, Local Poster Presentation |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Clinical/Research Fellows |
07/2023 - 06/2024 Nicole Boswell, Reseach Advisor, Medical Colleges of Wisconsin, Peer review publication in high impact journal |
PROGRAMMATIC DEVELOPMENTS: |
Clinical Programs |
2022 - Present Psoriasis and Psoriatic Arthritis Multidisciplinary Program |
COMMUNITY SERVICE ACTIVITIES: |
03/1997 - 07/1997 Volunteer Tutor - Mother Teresa's Missionary of Charity, India - Helped physically and mentally challenged children with their school assignments |
09/2004 - Present Annual outreach programs for Aman Foundation, India.
|
08/2006 - 12/2006 Volunteer Observer with Dr. Leigh Rosenblum - The Arc Medical Center, IL - Provide medical care to the underprivileged population of Chicago. Dispense free medications and food. |
2016 Arthritis Outreach Program, Ochsner Clinic, Slidell, LA |
09/2024 - Present Outreach Program for Arthritis Foundation, Milwaukee, WI |
LANGUAGES: |
Fluent in Hindi, Punjabi, and Urdu |
PRESS MENTIONS : |
03/2023 Biologics Show Signs of Delaying Arthritis in Psoriasis Patients. Medscape. March 9th, 2023:https://www.medscape.com/s/viewarticle/989414. |
03/2023 Biologic Choice Matters in PsA Prevention. htpps://www.nature.com/articles/s41584-023-00955-z.pdf |
04/2023 IL-12/23, IL-23 inhibitors reduce risk for progression to inflamatory arthritis vs. TNFi - https://www.healio.com/news/rheumatology/20230413/il1223-il23-inhibitors-reduce-risk-for-progression-to-invlamatory-arthritis-vs-tnfi - April 13, 2023 |
04/2023 Biologic Use for Psoriasis May Impact to Timing of Progression Inflammatory Arthritis. https://www.docwirenews.com/post/biologic-use-for-psoriasis-may-impact-to-timing-of-progression-to-inflammatory-arthritis |
06/2024 Multiple Reasons for Nonresponse. Medscape Medical News.https://www.medscape.com/viewarticle/whats-name-defining-difficult-treat-axspa-and-psa-2024a1000b5i?form=fpf |
07/2024 MACE Risk Similar Across Biologic Classes Used to Treat Psoriasis, Psoriatic Arthritis. https://www.medscape.com/viewarticle/mace-risk-similar-across-biologic-classes-used-treat-2024a1000dq0 |
12/14/2024 HealthCentral Newsletter: What’s the Difference Between Psoriatic Arthritis and Dermatomyositis |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Andre L Ribeiro, Shikha Singla, Vinod Chandran, Nicholas Chronis, Wilson Liao, Christine Lindsay, Enrique R Soriano, Philip J Mease, Fabian Profit. Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals. PMID: 38912423 PMCID: PMC11193309 DOI: 10.1093/rap/rkae074 |
2. Genasekaran TS, Singla S, Dahlberg M, Hernandez H, Berman JH. Is Gastroscope Better than Colonoscope in Pediatric Colonoscopy? Gastrointestinal Endoscopy, 2008 Apr; 67(5): AB253. doi: 10.1016/j.gie.2008.03.675 |
3. Gunasekaran TS, Singla S, Dahlberg M. Prescribing Proton-Pump Inhibitors to Irritable Infants; Where is the Evidence? Pediatric Health, 2009 Jun; 3(3): 213-215.doi:10/2217/phe.09.18 |
4. Lindwall E, Singla S, Davis W.E, Quinet RJ. Novel PSTPIP1 Gene Mutation in a Patient with Pyogenic Arthritis, Pyoderma Gangrenosum and Acne (PAPA) Syndrome. Seminars in Arthritis and Rheumatism, 2015 Aug; 45(1): 91-93 |
5. Singla S, Putman M, Liew J, Gordon K. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol. 2023 Apr;5(4):e200-e207. doi: 10.1016/S2665-9913(23)00034-6. Epub 2023 Mar 6. PMID: 38251522. |
6. Singla S, Eder L, Kaeley G, Aydin SZ. The Use and Availability of Musculoskeletal Ultrasonography for Psoriatic Disease Among Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Members and the Unmet Needs. Clin Ther. 2023 Sep;45(9):822-825. doi: 10.1016/j.clinthera.2023.06.005. Epub 2023 Jul 5. PMID: 37419859. |
7. Pedersen C, Tai S, Valley E, Henry K, Duarte-García A, Singla S, Putman M. Unpublished clinical trials of common rheumatic diseases. Rheumatology (Oxford). 2023 Dec 1;62(12):3811-3818. doi: 10.1093/rheumatology/kead141. PMID: 36971599. |
8. Singla S, Ribeiro A, Torgutalp M, Mease PJ, Proft F. Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project. RMD Open. 2024 Jan 8;10(1):e003809. doi: 10.1136/rmdopen-2023-003809. PMID: 38191215; PMCID: PMC10806599. |
9. Boswell ND, Singla S, Gordon KB. Sequencing of Targeted Therapy in Psoriasis: Does it Matter? Am J Clin Dermatol. 2024 Jul 13. doi: 10.1007/s40257-024-00874-z. Epub ahead of print. PMID: 39003351. |
10. Anumolu N, Rosenthal A, Sherman K, Singla S. Higher Rates of Psoriatic Arthritis in Patients with Calcium Pyrophosphate Deposition Disease than in Controls: A Retrospective Cohort Study. Gout, Urate, and Crystal Deposition Disease. 2025; 3(2):5. https://doi.org/10.3390/gucdd3020005 |
11. Andre L Ribeiro, Shikha Singla, Cameron Hay-Rollins, Nicholas Chronis, Wilson Liao, Christine Lindsay, Enrique R Soriano, Vinod Chandran, Jean-Guillaume Letarouilly, Philip J Mease, Fabian Proft, Deciphering difficult-to-treat psoriatic arthritis: insights from an international survey of patients with psoriatic arthritis, Rheumatology, 2025;, keaf207, https://doi.org/10.1093/rheumatology/keaf207 |
Editorials, Letters To Editor, Other |
1. Editorial Board - Rheumatology Advances in Practice 2023 |
2. Velasco J, Singla S, Putman M, Thorgerson AA, Suelzer E, Crayne CB. Further Investigation of Representation of Women as Authors of Rheumatology Articles From 2005 to 2020: Comment on the Article by Bagga et al. Arthritis Rheumatol. 2021 Mar;73(3):546-547. Epub 2021 Jan 29. PMID: 33142027 doi: 10.1002/art.41573 |
3. Singla S, Putman M, Liew J, Gordon K. Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis – Authors' reply, Lancet Rheumatol, 2023, Page e313. ISSN 2665-9913. doi: 10.1016/S2665-9913(23)00124-8. |
4. Shikha Singla, Dimitri Luz, Paradoxical psoriasis with IL-17 inhibitors, Rheumatology Advances in Practice, 2024;, rkae082, https://doi.org/10.1093/rap/rkae082 |
5. Roy D, Andreoli L, Ovseiko PV, Dey D, Ravindran Y, Singla S, Arredondo Gonzales AM, Toro-Gutierrez CE, Gupta L. Gender equity in global rheumatology awards. Ann Rheum Dis. 2024 Jun 12;83(7):958-959. doi: 10.1136/ard-2024-225670. PMID: 38519101 |
6. Mirza M, Liew JW, Putman M, Singla S. Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014-2024. Arthritis Rheumatol. 2025 Apr 23. doi: 10.1002/art.43198. Epub ahead of print. PMID: 40268285. |
Non-Refereed Journal Publications/Original Papers |
1. Iryna Nemesh, MD, Saleema Kherani, MD MPH, Shikha Singla, MD & William Wirostko, MD. Case Report: A Rare Mimic of Giant Cell Arteritis. The Rheumatologist 2021, Nov 14: 42-43 https://www.the-rheumatologist.org/article/case-report-a-rare-mimic-of-giant-cell-arteritis/ |
Database, Video, or Other Research/Clinical Contributions |
1. Podcast at Cytokine Signaling Forum: "Author Interview" 4/2023 https://www.youtube.com/watch?v=m342x6ctapk |
2. Podcast at RheumNow: "Psoriasis for Rheumatologist" 10/2023
https://rheumnow.com/therapeutic-update/psoriasis-rheumatologists |
3. Podcast at Inside GRAPPA: "Difficult-to-treat Psoriatic Arthritis Project Episode" 4/2025 |
